nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—HRH1—atherosclerosis	0.464	1	CbGaD
Thioridazine—CYP2C8—Simvastatin—atherosclerosis	0.0314	0.0907	CbGbCtD
Thioridazine—CYP2C8—Pravastatin—atherosclerosis	0.0307	0.0888	CbGbCtD
Thioridazine—CYP2C8—Lovastatin—atherosclerosis	0.0307	0.0888	CbGbCtD
Thioridazine—CYP2C19—Rosuvastatin—atherosclerosis	0.0283	0.0818	CbGbCtD
Thioridazine—CYP2C19—Simvastatin—atherosclerosis	0.0263	0.0761	CbGbCtD
Thioridazine—CYP2C19—Lovastatin—atherosclerosis	0.0258	0.0745	CbGbCtD
Thioridazine—CYP2D6—Niacin—atherosclerosis	0.0253	0.0732	CbGbCtD
Thioridazine—CYP2C9—Rosuvastatin—atherosclerosis	0.0236	0.068	CbGbCtD
Thioridazine—CYP2C9—Simvastatin—atherosclerosis	0.0219	0.0633	CbGbCtD
Thioridazine—CYP2C9—Lovastatin—atherosclerosis	0.0214	0.0619	CbGbCtD
Thioridazine—CYP2C9—Pravastatin—atherosclerosis	0.0214	0.0619	CbGbCtD
Thioridazine—CYP2D6—Simvastatin—atherosclerosis	0.02	0.0578	CbGbCtD
Thioridazine—CYP2D6—Lovastatin—atherosclerosis	0.0196	0.0566	CbGbCtD
Thioridazine—CYP2D6—Pravastatin—atherosclerosis	0.0196	0.0566	CbGbCtD
Thioridazine—HTR2A—arteriole—atherosclerosis	0.00254	0.137	CbGeAlD
Thioridazine—HTR7—vein—atherosclerosis	0.00243	0.131	CbGeAlD
Thioridazine—Systemic lupus erythematosus—Lovastatin—atherosclerosis	0.00228	0.0302	CcSEcCtD
Thioridazine—Systemic lupus erythematosus—Simvastatin—atherosclerosis	0.00213	0.0282	CcSEcCtD
Thioridazine—Systemic lupus erythematosus—Pravastatin—atherosclerosis	0.00193	0.0255	CcSEcCtD
Thioridazine—Blood disorder—Rosuvastatin—atherosclerosis	0.00178	0.0236	CcSEcCtD
Thioridazine—Laryngeal oedema—Niacin—atherosclerosis	0.00169	0.0223	CcSEcCtD
Thioridazine—HTR2A—vein—atherosclerosis	0.00152	0.0814	CbGeAlD
Thioridazine—Cholestasis—Niacin—atherosclerosis	0.00143	0.0189	CcSEcCtD
Thioridazine—Hepatotoxicity—Niacin—atherosclerosis	0.0014	0.0186	CcSEcCtD
Thioridazine—Gynaecomastia—Rosuvastatin—atherosclerosis	0.00133	0.0176	CcSEcCtD
Thioridazine—Gynaecomastia—Lovastatin—atherosclerosis	0.00113	0.0149	CcSEcCtD
Thioridazine—Dermatitis contact—Niacin—atherosclerosis	0.00107	0.0142	CcSEcCtD
Thioridazine—Gynaecomastia—Simvastatin—atherosclerosis	0.00106	0.014	CcSEcCtD
Thioridazine—Photosensitivity—Lovastatin—atherosclerosis	0.00104	0.0138	CcSEcCtD
Thioridazine—Photosensitivity—Ezetimibe—atherosclerosis	0.00102	0.0135	CcSEcCtD
Thioridazine—HTR2A—hindlimb—atherosclerosis	0.00101	0.0541	CbGeAlD
Thioridazine—HTR7—artery—atherosclerosis	0.00099	0.0532	CbGeAlD
Thioridazine—Photosensitivity—Simvastatin—atherosclerosis	0.000976	0.0129	CcSEcCtD
Thioridazine—Gynaecomastia—Pravastatin—atherosclerosis	0.000955	0.0126	CcSEcCtD
Thioridazine—Photosensitivity—Pravastatin—atherosclerosis	0.000882	0.0117	CcSEcCtD
Thioridazine—HTR2A—appendage—atherosclerosis	0.000864	0.0464	CbGeAlD
Thioridazine—HTR7—endothelium—atherosclerosis	0.000837	0.0449	CbGeAlD
Thioridazine—Jaundice—Rosuvastatin—atherosclerosis	0.000812	0.0107	CcSEcCtD
Thioridazine—Eosinophilia—Lovastatin—atherosclerosis	0.000784	0.0104	CcSEcCtD
Thioridazine—HTR7—blood vessel—atherosclerosis	0.000771	0.0414	CbGeAlD
Thioridazine—Eosinophilia—Ezetimibe—atherosclerosis	0.000769	0.0102	CcSEcCtD
Thioridazine—Eosinophilia—Simvastatin—atherosclerosis	0.000733	0.0097	CcSEcCtD
Thioridazine—Photosensitivity reaction—Lovastatin—atherosclerosis	0.000723	0.00956	CcSEcCtD
Thioridazine—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.000709	0.00938	CcSEcCtD
Thioridazine—Photosensitivity reaction—Simvastatin—atherosclerosis	0.000676	0.00895	CcSEcCtD
Thioridazine—Jaundice—Ezetimibe—atherosclerosis	0.000675	0.00893	CcSEcCtD
Thioridazine—Arrhythmia—Rosuvastatin—atherosclerosis	0.000668	0.00884	CcSEcCtD
Thioridazine—Isothipendyl—HRH1—atherosclerosis	0.000668	0.118	CrCbGaD
Thioridazine—Eosinophilia—Pravastatin—atherosclerosis	0.000663	0.00877	CcSEcCtD
Thioridazine—Mental disorder—Rosuvastatin—atherosclerosis	0.000655	0.00867	CcSEcCtD
Thioridazine—Sweating increased—Pravastatin—atherosclerosis	0.000652	0.00863	CcSEcCtD
Thioridazine—Jaundice—Simvastatin—atherosclerosis	0.000644	0.00852	CcSEcCtD
Thioridazine—HTR2A—artery—atherosclerosis	0.000618	0.0332	CbGeAlD
Thioridazine—Oedema peripheral—Ezetimibe—atherosclerosis	0.000613	0.0081	CcSEcCtD
Thioridazine—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000611	0.00809	CcSEcCtD
Thioridazine—Weight increased—Pravastatin—atherosclerosis	0.00061	0.00806	CcSEcCtD
Thioridazine—Angioedema—Rosuvastatin—atherosclerosis	0.000595	0.00787	CcSEcCtD
Thioridazine—Jaundice—Niacin—atherosclerosis	0.000591	0.00782	CcSEcCtD
Thioridazine—Jaundice—Pravastatin—atherosclerosis	0.000582	0.0077	CcSEcCtD
Thioridazine—Aceprometazine—HRH1—atherosclerosis	0.000578	0.102	CrCbGaD
Thioridazine—Mental disorder—Ezetimibe—atherosclerosis	0.000545	0.00721	CcSEcCtD
Thioridazine—Erythema—Ezetimibe—atherosclerosis	0.000541	0.00716	CcSEcCtD
Thioridazine—Oedema peripheral—Niacin—atherosclerosis	0.000536	0.0071	CcSEcCtD
Thioridazine—Confusional state—Rosuvastatin—atherosclerosis	0.000536	0.00709	CcSEcCtD
Thioridazine—Methdilazine—HRH1—atherosclerosis	0.000535	0.0945	CrCbGaD
Thioridazine—Clemastine—HRH1—atherosclerosis	0.000525	0.0927	CrCbGaD
Thioridazine—HTR2A—endothelium—atherosclerosis	0.000522	0.028	CbGeAlD
Thioridazine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00052	0.00688	CcSEcCtD
Thioridazine—Vision blurred—Lovastatin—atherosclerosis	0.00052	0.00688	CcSEcCtD
Thioridazine—Mental disorder—Simvastatin—atherosclerosis	0.000519	0.00687	CcSEcCtD
Thioridazine—Tremor—Lovastatin—atherosclerosis	0.000517	0.00684	CcSEcCtD
Thioridazine—Erythema—Simvastatin—atherosclerosis	0.000516	0.00683	CcSEcCtD
Thioridazine—Angioedema—Lovastatin—atherosclerosis	0.000504	0.00667	CcSEcCtD
Thioridazine—Anaemia—Ezetimibe—atherosclerosis	0.0005	0.00662	CcSEcCtD
Thioridazine—Angioedema—Ezetimibe—atherosclerosis	0.000495	0.00654	CcSEcCtD
Thioridazine—Leukopenia—Lovastatin—atherosclerosis	0.000494	0.00654	CcSEcCtD
Thioridazine—Vision blurred—Simvastatin—atherosclerosis	0.000486	0.00644	CcSEcCtD
Thioridazine—Arrhythmia—Niacin—atherosclerosis	0.000486	0.00644	CcSEcCtD
Thioridazine—Tremor—Simvastatin—atherosclerosis	0.000484	0.0064	CcSEcCtD
Thioridazine—HTR2A—blood vessel—atherosclerosis	0.000481	0.0258	CbGeAlD
Thioridazine—Arrhythmia—Pravastatin—atherosclerosis	0.000479	0.00634	CcSEcCtD
Thioridazine—Anaemia—Simvastatin—atherosclerosis	0.000477	0.00631	CcSEcCtD
Thioridazine—Erythema—Niacin—atherosclerosis	0.000474	0.00627	CcSEcCtD
Thioridazine—Angioedema—Simvastatin—atherosclerosis	0.000472	0.00624	CcSEcCtD
Thioridazine—Leukopenia—Simvastatin—atherosclerosis	0.000462	0.00611	CcSEcCtD
Thioridazine—Constipation—Rosuvastatin—atherosclerosis	0.000454	0.00601	CcSEcCtD
Thioridazine—Confusional state—Lovastatin—atherosclerosis	0.000454	0.00601	CcSEcCtD
Thioridazine—Vision blurred—Niacin—atherosclerosis	0.000447	0.00591	CcSEcCtD
Thioridazine—Confusional state—Ezetimibe—atherosclerosis	0.000445	0.00589	CcSEcCtD
Thioridazine—CHRM2—cardiovascular system—atherosclerosis	0.000444	0.0238	CbGeAlD
Thioridazine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000441	0.00583	CcSEcCtD
Thioridazine—Vision blurred—Pravastatin—atherosclerosis	0.00044	0.00582	CcSEcCtD
Thioridazine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000438	0.00579	CcSEcCtD
Thioridazine—Tremor—Pravastatin—atherosclerosis	0.000437	0.00578	CcSEcCtD
Thioridazine—Angioedema—Niacin—atherosclerosis	0.000433	0.00573	CcSEcCtD
Thioridazine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000433	0.00572	CcSEcCtD
Thioridazine—Anaemia—Pravastatin—atherosclerosis	0.000431	0.00571	CcSEcCtD
Thioridazine—Anorexia—Lovastatin—atherosclerosis	0.000429	0.00568	CcSEcCtD
Thioridazine—Angioedema—Pravastatin—atherosclerosis	0.000426	0.00564	CcSEcCtD
Thioridazine—Confusional state—Simvastatin—atherosclerosis	0.000425	0.00562	CcSEcCtD
Thioridazine—Leukopenia—Niacin—atherosclerosis	0.000424	0.00561	CcSEcCtD
Thioridazine—Oedema—Simvastatin—atherosclerosis	0.000421	0.00557	CcSEcCtD
Thioridazine—Leukopenia—Pravastatin—atherosclerosis	0.000418	0.00553	CcSEcCtD
Thioridazine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000412	0.00546	CcSEcCtD
Thioridazine—Anorexia—Simvastatin—atherosclerosis	0.000402	0.00531	CcSEcCtD
Thioridazine—HTR7—connective tissue—atherosclerosis	0.000396	0.0212	CbGeAlD
Thioridazine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000392	0.00518	CcSEcCtD
Thioridazine—Decreased appetite—Lovastatin—atherosclerosis	0.000392	0.00518	CcSEcCtD
Thioridazine—Alimemazine—HRH1—atherosclerosis	0.00039	0.069	CrCbGaD
Thioridazine—Oedema—Niacin—atherosclerosis	0.000387	0.00512	CcSEcCtD
Thioridazine—Constipation—Lovastatin—atherosclerosis	0.000385	0.0051	CcSEcCtD
Thioridazine—Confusional state—Pravastatin—atherosclerosis	0.000384	0.00508	CcSEcCtD
Thioridazine—Decreased appetite—Ezetimibe—atherosclerosis	0.000384	0.00508	CcSEcCtD
Thioridazine—Oedema—Pravastatin—atherosclerosis	0.000381	0.00504	CcSEcCtD
Thioridazine—Constipation—Ezetimibe—atherosclerosis	0.000378	0.005	CcSEcCtD
Thioridazine—Tachycardia—Niacin—atherosclerosis	0.000378	0.00499	CcSEcCtD
Thioridazine—Hyperhidrosis—Niacin—atherosclerosis	0.000374	0.00495	CcSEcCtD
Thioridazine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000373	0.00493	CcSEcCtD
Thioridazine—Feeling abnormal—Lovastatin—atherosclerosis	0.000371	0.00491	CcSEcCtD
Thioridazine—Anorexia—Niacin—atherosclerosis	0.000369	0.00488	CcSEcCtD
Thioridazine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000368	0.00487	CcSEcCtD
Thioridazine—Decreased appetite—Simvastatin—atherosclerosis	0.000366	0.00485	CcSEcCtD
Thioridazine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000364	0.00482	CcSEcCtD
Thioridazine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000364	0.00481	CcSEcCtD
Thioridazine—Anorexia—Pravastatin—atherosclerosis	0.000363	0.0048	CcSEcCtD
Thioridazine—Hypotension—Niacin—atherosclerosis	0.000361	0.00478	CcSEcCtD
Thioridazine—Constipation—Simvastatin—atherosclerosis	0.00036	0.00477	CcSEcCtD
Thioridazine—HTR1A—cardiovascular system—atherosclerosis	0.00036	0.0193	CbGeAlD
Thioridazine—Body temperature increased—Lovastatin—atherosclerosis	0.000356	0.00471	CcSEcCtD
Thioridazine—Body temperature increased—Ezetimibe—atherosclerosis	0.000349	0.00462	CcSEcCtD
Thioridazine—Feeling abnormal—Simvastatin—atherosclerosis	0.000347	0.00459	CcSEcCtD
Thioridazine—HTR7—cardiovascular system—atherosclerosis	0.000344	0.0185	CbGeAlD
Thioridazine—Somnolence—Niacin—atherosclerosis	0.000344	0.00455	CcSEcCtD
Thioridazine—Decreased appetite—Niacin—atherosclerosis	0.000336	0.00445	CcSEcCtD
Thioridazine—Mequitazine—HRH1—atherosclerosis	0.000336	0.0594	CrCbGaD
Thioridazine—Rash—Rosuvastatin—atherosclerosis	0.000335	0.00443	CcSEcCtD
Thioridazine—Dermatitis—Rosuvastatin—atherosclerosis	0.000335	0.00443	CcSEcCtD
Thioridazine—Body temperature increased—Simvastatin—atherosclerosis	0.000333	0.00441	CcSEcCtD
Thioridazine—Headache—Rosuvastatin—atherosclerosis	0.000333	0.0044	CcSEcCtD
Thioridazine—ADRA1A—cardiovascular system—atherosclerosis	0.000332	0.0178	CbGeAlD
Thioridazine—Hypersensitivity—Lovastatin—atherosclerosis	0.000332	0.00439	CcSEcCtD
Thioridazine—Decreased appetite—Pravastatin—atherosclerosis	0.000331	0.00438	CcSEcCtD
Thioridazine—Constipation—Pravastatin—atherosclerosis	0.000326	0.00431	CcSEcCtD
Thioridazine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000325	0.00431	CcSEcCtD
Thioridazine—KCNH2—cardiovascular system—atherosclerosis	0.000321	0.0172	CbGeAlD
Thioridazine—Nausea—Rosuvastatin—atherosclerosis	0.000316	0.00418	CcSEcCtD
Thioridazine—Feeling abnormal—Pravastatin—atherosclerosis	0.000314	0.00415	CcSEcCtD
Thioridazine—Hypersensitivity—Simvastatin—atherosclerosis	0.00031	0.00411	CcSEcCtD
Thioridazine—Diarrhoea—Lovastatin—atherosclerosis	0.000308	0.00408	CcSEcCtD
Thioridazine—Body temperature increased—Niacin—atherosclerosis	0.000306	0.00405	CcSEcCtD
Thioridazine—Diarrhoea—Ezetimibe—atherosclerosis	0.000302	0.004	CcSEcCtD
Thioridazine—Body temperature increased—Pravastatin—atherosclerosis	0.000301	0.00398	CcSEcCtD
Thioridazine—HRH1—connective tissue—atherosclerosis	0.000295	0.0159	CbGeAlD
Thioridazine—ADRA1A—adipose tissue—atherosclerosis	0.000293	0.0157	CbGeAlD
Thioridazine—ADRA2A—connective tissue—atherosclerosis	0.00029	0.0156	CbGeAlD
Thioridazine—Diarrhoea—Simvastatin—atherosclerosis	0.000288	0.00381	CcSEcCtD
Thioridazine—Vomiting—Lovastatin—atherosclerosis	0.000286	0.00379	CcSEcCtD
Thioridazine—Hypersensitivity—Niacin—atherosclerosis	0.000285	0.00377	CcSEcCtD
Thioridazine—Rash—Lovastatin—atherosclerosis	0.000284	0.00376	CcSEcCtD
Thioridazine—Dermatitis—Lovastatin—atherosclerosis	0.000284	0.00375	CcSEcCtD
Thioridazine—Headache—Lovastatin—atherosclerosis	0.000282	0.00373	CcSEcCtD
Thioridazine—Vomiting—Ezetimibe—atherosclerosis	0.000281	0.00372	CcSEcCtD
Thioridazine—Hypersensitivity—Pravastatin—atherosclerosis	0.000281	0.00371	CcSEcCtD
Thioridazine—Rash—Ezetimibe—atherosclerosis	0.000279	0.00369	CcSEcCtD
Thioridazine—Dermatitis—Ezetimibe—atherosclerosis	0.000278	0.00368	CcSEcCtD
Thioridazine—Zuclopenthixol—HRH1—atherosclerosis	0.000277	0.049	CrCbGaD
Thioridazine—Headache—Ezetimibe—atherosclerosis	0.000277	0.00366	CcSEcCtD
Thioridazine—Vomiting—Simvastatin—atherosclerosis	0.000268	0.00354	CcSEcCtD
Thioridazine—Nausea—Lovastatin—atherosclerosis	0.000268	0.00354	CcSEcCtD
Thioridazine—Rash—Simvastatin—atherosclerosis	0.000266	0.00351	CcSEcCtD
Thioridazine—Dermatitis—Simvastatin—atherosclerosis	0.000265	0.00351	CcSEcCtD
Thioridazine—Diarrhoea—Niacin—atherosclerosis	0.000265	0.0035	CcSEcCtD
Thioridazine—Headache—Simvastatin—atherosclerosis	0.000264	0.00349	CcSEcCtD
Thioridazine—Nausea—Ezetimibe—atherosclerosis	0.000262	0.00347	CcSEcCtD
Thioridazine—Diarrhoea—Pravastatin—atherosclerosis	0.000261	0.00345	CcSEcCtD
Thioridazine—CYP2C9—cardiovascular system—atherosclerosis	0.000261	0.014	CbGeAlD
Thioridazine—Nausea—Simvastatin—atherosclerosis	0.00025	0.00331	CcSEcCtD
Thioridazine—CYP2E1—cardiovascular system—atherosclerosis	0.000247	0.0133	CbGeAlD
Thioridazine—HTR2A—connective tissue—atherosclerosis	0.000247	0.0132	CbGeAlD
Thioridazine—Vomiting—Niacin—atherosclerosis	0.000246	0.00325	CcSEcCtD
Thioridazine—Rash—Niacin—atherosclerosis	0.000244	0.00323	CcSEcCtD
Thioridazine—Dermatitis—Niacin—atherosclerosis	0.000244	0.00322	CcSEcCtD
Thioridazine—Headache—Niacin—atherosclerosis	0.000242	0.00321	CcSEcCtD
Thioridazine—Vomiting—Pravastatin—atherosclerosis	0.000242	0.0032	CcSEcCtD
Thioridazine—Rash—Pravastatin—atherosclerosis	0.00024	0.00318	CcSEcCtD
Thioridazine—Dermatitis—Pravastatin—atherosclerosis	0.00024	0.00317	CcSEcCtD
Thioridazine—Thiothixene—HRH1—atherosclerosis	0.000239	0.0422	CrCbGaD
Thioridazine—Headache—Pravastatin—atherosclerosis	0.000239	0.00316	CcSEcCtD
Thioridazine—Mesoridazine—HRH1—atherosclerosis	0.000236	0.0417	CrCbGaD
Thioridazine—Nausea—Niacin—atherosclerosis	0.00023	0.00304	CcSEcCtD
Thioridazine—Prochlorperazine—HRH1—atherosclerosis	0.000228	0.0404	CrCbGaD
Thioridazine—HRH1—adipose tissue—atherosclerosis	0.000227	0.0122	CbGeAlD
Thioridazine—Nausea—Pravastatin—atherosclerosis	0.000226	0.00299	CcSEcCtD
Thioridazine—ADRA2A—adipose tissue—atherosclerosis	0.000223	0.012	CbGeAlD
Thioridazine—HTR2A—cardiovascular system—atherosclerosis	0.000215	0.0115	CbGeAlD
Thioridazine—HTR7—liver—atherosclerosis	0.000213	0.0114	CbGeAlD
Thioridazine—CYP2C19—liver—atherosclerosis	0.000208	0.0112	CbGeAlD
Thioridazine—Fluphenazine—HRH1—atherosclerosis	0.000207	0.0365	CrCbGaD
Thioridazine—ADRA1A—liver—atherosclerosis	0.000205	0.011	CbGeAlD
Thioridazine—Propiomazine—HRH1—atherosclerosis	0.000199	0.0351	CrCbGaD
Thioridazine—CYP2C8—liver—atherosclerosis	0.000181	0.00974	CbGeAlD
Thioridazine—Methotrimeprazine—HRH1—atherosclerosis	0.00017	0.03	CrCbGaD
Thioridazine—CYP1A2—liver—atherosclerosis	0.00017	0.00912	CbGeAlD
Thioridazine—Promethazine—HRH1—atherosclerosis	0.000167	0.0296	CrCbGaD
Thioridazine—Trifluoperazine—HRH1—atherosclerosis	0.000165	0.0292	CrCbGaD
Thioridazine—Perphenazine—HRH1—atherosclerosis	0.000163	0.0289	CrCbGaD
Thioridazine—CYP2C9—liver—atherosclerosis	0.000161	0.00865	CbGeAlD
Thioridazine—CYP2E1—liver—atherosclerosis	0.000153	0.0082	CbGeAlD
Thioridazine—Promazine—HRH1—atherosclerosis	0.000147	0.026	CrCbGaD
Thioridazine—HTR2A—liver—atherosclerosis	0.000133	0.00713	CbGeAlD
Thioridazine—Chlorpromazine—HRH1—atherosclerosis	0.00013	0.0229	CrCbGaD
Thioridazine—CYP2D6—liver—atherosclerosis	0.000121	0.00649	CbGeAlD
Thioridazine—Acepromazine—ALB—atherosclerosis	5.74e-05	0.0101	CrCbGaD
Thioridazine—Thioproperazine—ALB—atherosclerosis	5.61e-05	0.00991	CrCbGaD
Thioridazine—Thiothixene—ALB—atherosclerosis	5.52e-05	0.00975	CrCbGaD
Thioridazine—Pipotiazine—ALB—atherosclerosis	5.52e-05	0.00975	CrCbGaD
Thioridazine—Clomipramine—ALB—atherosclerosis	4.36e-05	0.00771	CrCbGaD
Thioridazine—Chlorpromazine—ALB—atherosclerosis	2.99e-05	0.00529	CrCbGaD
Thioridazine—ADRA2A—Metabolism—ALB—atherosclerosis	4.29e-06	4.78e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—IL6—atherosclerosis	4.28e-06	4.77e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	4.27e-06	4.76e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	4.26e-06	4.75e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—LPL—atherosclerosis	4.26e-06	4.75e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—VEGFA—atherosclerosis	4.25e-06	4.74e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—VEGFA—atherosclerosis	4.24e-06	4.73e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CCL2—atherosclerosis	4.23e-06	4.72e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IGF1—atherosclerosis	4.23e-06	4.71e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—INS—atherosclerosis	4.22e-06	4.71e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CCL2—atherosclerosis	4.22e-06	4.71e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—LPL—atherosclerosis	4.22e-06	4.7e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—INS—atherosclerosis	4.21e-06	4.69e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—STAT3—atherosclerosis	4.21e-06	4.69e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—STAT3—atherosclerosis	4.2e-06	4.68e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—MTHFR—atherosclerosis	4.17e-06	4.65e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IGF1—atherosclerosis	4.16e-06	4.64e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—NOS3—atherosclerosis	4.16e-06	4.63e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CCL2—atherosclerosis	4.15e-06	4.63e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—GPX1—atherosclerosis	4.15e-06	4.63e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IGF1—atherosclerosis	4.15e-06	4.63e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	4.14e-06	4.62e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PIK3CG—atherosclerosis	4.13e-06	4.61e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—GPX1—atherosclerosis	4.12e-06	4.59e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—NOS3—atherosclerosis	4.1e-06	4.57e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PPARA—atherosclerosis	4.09e-06	4.56e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IGF1—atherosclerosis	4.08e-06	4.55e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	4.07e-06	4.54e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—MMP9—atherosclerosis	4.07e-06	4.54e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CD36—atherosclerosis	4.05e-06	4.51e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—NFKB1—atherosclerosis	4.03e-06	4.49e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—MAPK3—atherosclerosis	4.02e-06	4.48e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—MAPK3—atherosclerosis	4.01e-06	4.47e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—SERPINE1—atherosclerosis	4.01e-06	4.47e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CD36—atherosclerosis	4.01e-06	4.47e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—MAPK8—atherosclerosis	3.96e-06	4.41e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—AGT—atherosclerosis	3.96e-06	4.41e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—MAPK3—atherosclerosis	3.96e-06	4.41e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—AKT1—atherosclerosis	3.95e-06	4.4e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—SERPINE1—atherosclerosis	3.95e-06	4.4e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—HMOX1—atherosclerosis	3.94e-06	4.4e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—SERPINE1—atherosclerosis	3.94e-06	4.39e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—ALB—atherosclerosis	3.94e-06	4.39e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PIK3CG—atherosclerosis	3.92e-06	4.37e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—INS—atherosclerosis	3.91e-06	4.36e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TGFB1—atherosclerosis	3.9e-06	4.35e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TGFB1—atherosclerosis	3.9e-06	4.34e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—APOE—atherosclerosis	3.88e-06	4.32e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	3.88e-06	4.32e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CXCL8—atherosclerosis	3.87e-06	4.32e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	3.87e-06	4.31e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CXCL8—atherosclerosis	3.85e-06	4.29e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CCL2—atherosclerosis	3.85e-06	4.29e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—CAV1—atherosclerosis	3.84e-06	4.28e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—APOA1—atherosclerosis	3.84e-06	4.28e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—MTHFR—atherosclerosis	3.83e-06	4.27e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—NOS3—atherosclerosis	3.83e-06	4.27e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—MTHFR—atherosclerosis	3.8e-06	4.24e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PPARG—atherosclerosis	3.79e-06	4.22e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	3.78e-06	4.22e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—APOB—atherosclerosis	3.78e-06	4.21e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—NOS3—atherosclerosis	3.77e-06	4.2e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—NOS3—atherosclerosis	3.77e-06	4.2e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—NOS3—atherosclerosis	3.76e-06	4.19e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PPARA—atherosclerosis	3.76e-06	4.19e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PTGS2—atherosclerosis	3.75e-06	4.18e-05	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—AKT1—atherosclerosis	3.74e-06	4.17e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PPARA—atherosclerosis	3.73e-06	4.16e-05	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—AKT1—atherosclerosis	3.72e-06	4.15e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—INS—atherosclerosis	3.71e-06	4.14e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—NOS3—atherosclerosis	3.7e-06	4.13e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	3.69e-06	4.12e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CXCL8—atherosclerosis	3.69e-06	4.11e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—IL6—atherosclerosis	3.68e-06	4.1e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—GSTM1—atherosclerosis	3.67e-06	4.1e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—IL6—atherosclerosis	3.66e-06	4.08e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—VEGFA—atherosclerosis	3.66e-06	4.08e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—AGT—atherosclerosis	3.64e-06	4.06e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—STAT3—atherosclerosis	3.62e-06	4.04e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—AGT—atherosclerosis	3.61e-06	4.02e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—LPL—atherosclerosis	3.61e-06	4.02e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	3.59e-06	4.01e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—APOE—atherosclerosis	3.57e-06	3.98e-05	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	3.56e-06	3.97e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—APOE—atherosclerosis	3.54e-06	3.94e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CAV1—atherosclerosis	3.54e-06	3.94e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—APOA1—atherosclerosis	3.53e-06	3.93e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—GPX1—atherosclerosis	3.52e-06	3.92e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	3.51e-06	3.91e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CAV1—atherosclerosis	3.51e-06	3.91e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MMP9—atherosclerosis	3.5e-06	3.9e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	3.5e-06	3.9e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—APOA1—atherosclerosis	3.5e-06	3.9e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MMP9—atherosclerosis	3.48e-06	3.88e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	3.47e-06	3.86e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—MAPK3—atherosclerosis	3.46e-06	3.86e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—NFKB1—atherosclerosis	3.45e-06	3.84e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PTGS2—atherosclerosis	3.45e-06	3.84e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	3.43e-06	3.82e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CD36—atherosclerosis	3.43e-06	3.82e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	3.41e-06	3.8e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—ALB—atherosclerosis	3.4e-06	3.79e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CXCL8—atherosclerosis	3.4e-06	3.79e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	3.4e-06	3.79e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MAPK8—atherosclerosis	3.39e-06	3.78e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PPARG—atherosclerosis	3.38e-06	3.77e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—AKT1—atherosclerosis	3.38e-06	3.77e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TGFB1—atherosclerosis	3.36e-06	3.74e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	3.35e-06	3.73e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CXCL8—atherosclerosis	3.34e-06	3.72e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	3.34e-06	3.72e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—INS—atherosclerosis	3.31e-06	3.69e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	3.3e-06	3.68e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	3.28e-06	3.66e-05	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	3.28e-06	3.66e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	3.28e-06	3.65e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—NOS3—atherosclerosis	3.26e-06	3.63e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—MTHFR—atherosclerosis	3.25e-06	3.62e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	3.24e-06	3.62e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	3.23e-06	3.61e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—IL6—atherosclerosis	3.23e-06	3.6e-05	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	3.23e-06	3.6e-05	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	3.22e-06	3.59e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	3.22e-06	3.59e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CG—atherosclerosis	3.19e-06	3.56e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PPARA—atherosclerosis	3.19e-06	3.55e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—IL6—atherosclerosis	3.18e-06	3.55e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—IL6—atherosclerosis	3.17e-06	3.54e-05	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	3.17e-06	3.54e-05	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	3.16e-06	3.53e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	3.14e-06	3.51e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—VEGFA—atherosclerosis	3.13e-06	3.49e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—IL6—atherosclerosis	3.12e-06	3.48e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	3.11e-06	3.47e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—STAT3—atherosclerosis	3.11e-06	3.47e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PPARG—atherosclerosis	3.11e-06	3.46e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—STAT3—atherosclerosis	3.1e-06	3.45e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—AGT—atherosclerosis	3.09e-06	3.44e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PPARG—atherosclerosis	3.08e-06	3.43e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MMP9—atherosclerosis	3.08e-06	3.43e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—INS—atherosclerosis	3.05e-06	3.4e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	3.04e-06	3.39e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—NFKB1—atherosclerosis	3.04e-06	3.39e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—ALB—atherosclerosis	3.04e-06	3.39e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MMP9—atherosclerosis	3.03e-06	3.37e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—APOE—atherosclerosis	3.02e-06	3.37e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—INS—atherosclerosis	3.02e-06	3.37e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MMP9—atherosclerosis	3.02e-06	3.37e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CAV1—atherosclerosis	3e-06	3.34e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	3e-06	3.34e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	2.99e-06	3.34e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MAPK8—atherosclerosis	2.99e-06	3.33e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—APOA1—atherosclerosis	2.99e-06	3.33e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—NFKB1—atherosclerosis	2.99e-06	3.33e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—AKT1—atherosclerosis	2.98e-06	3.32e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PTGS2—atherosclerosis	2.98e-06	3.32e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	2.98e-06	3.32e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MMP9—atherosclerosis	2.97e-06	3.31e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	2.97e-06	3.31e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	2.96e-06	3.3e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MAPK3—atherosclerosis	2.96e-06	3.3e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	2.94e-06	3.28e-05	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	2.94e-06	3.28e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	2.94e-06	3.28e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IL6—atherosclerosis	2.94e-06	3.28e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MAPK8—atherosclerosis	2.94e-06	3.27e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IL6—atherosclerosis	2.94e-06	3.27e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	2.93e-06	3.27e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	2.93e-06	3.27e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—AKT1—atherosclerosis	2.93e-06	3.26e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—NOS3—atherosclerosis	2.91e-06	3.24e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	2.89e-06	3.23e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	2.89e-06	3.22e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	2.89e-06	3.22e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	2.88e-06	3.21e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	2.88e-06	3.21e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	2.87e-06	3.2e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TGFB1—atherosclerosis	2.87e-06	3.2e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	2.83e-06	3.16e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—ALB—atherosclerosis	2.8e-06	3.12e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—ALB—atherosclerosis	2.77e-06	3.09e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—VEGFA—atherosclerosis	2.76e-06	3.08e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	2.75e-06	3.07e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	2.75e-06	3.06e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—STAT3—atherosclerosis	2.73e-06	3.05e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	2.73e-06	3.04e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	2.72e-06	3.04e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	2.72e-06	3.03e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—VEGFA—atherosclerosis	2.71e-06	3.02e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—AKT1—atherosclerosis	2.71e-06	3.02e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—AKT1—atherosclerosis	2.71e-06	3.02e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—STAT3—atherosclerosis	2.69e-06	3e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—STAT3—atherosclerosis	2.68e-06	2.99e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	2.68e-06	2.98e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—NOS3—atherosclerosis	2.67e-06	2.98e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	2.67e-06	2.98e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	2.67e-06	2.97e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	2.66e-06	2.97e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PTGS2—atherosclerosis	2.66e-06	2.96e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—NOS3—atherosclerosis	2.65e-06	2.95e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—STAT3—atherosclerosis	2.64e-06	2.94e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	2.63e-06	2.94e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PPARG—atherosclerosis	2.63e-06	2.94e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MAPK3—atherosclerosis	2.61e-06	2.91e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—INS—atherosclerosis	2.58e-06	2.88e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	2.57e-06	2.86e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MAPK3—atherosclerosis	2.56e-06	2.86e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TGFB1—atherosclerosis	2.53e-06	2.82e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IL6—atherosclerosis	2.53e-06	2.82e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	2.52e-06	2.81e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	2.52e-06	2.8e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	2.49e-06	2.78e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TGFB1—atherosclerosis	2.49e-06	2.77e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	2.47e-06	2.75e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	2.45e-06	2.73e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	2.45e-06	2.73e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PTGS2—atherosclerosis	2.45e-06	2.73e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	2.44e-06	2.72e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.42e-06	2.7e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ALB—atherosclerosis	2.37e-06	2.64e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	2.34e-06	2.61e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—AKT1—atherosclerosis	2.33e-06	2.6e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	2.27e-06	2.53e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—NOS3—atherosclerosis	2.27e-06	2.52e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL6—atherosclerosis	2.18e-06	2.42e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL6—atherosclerosis	2.16e-06	2.41e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PTGS2—atherosclerosis	2.07e-06	2.31e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL6—atherosclerosis	2.07e-06	2.31e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—AKT1—atherosclerosis	2.01e-06	2.24e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—AKT1—atherosclerosis	2e-06	2.23e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	1.91e-06	2.13e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL6—atherosclerosis	1.91e-06	2.13e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—AKT1—atherosclerosis	1.89e-06	2.1e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL6—atherosclerosis	1.88e-06	2.09e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL6—atherosclerosis	1.88e-06	2.09e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL6—atherosclerosis	1.85e-06	2.06e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL6—atherosclerosis	1.84e-06	2.05e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—AKT1—atherosclerosis	1.76e-06	1.96e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—AKT1—atherosclerosis	1.73e-06	1.93e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—AKT1—atherosclerosis	1.73e-06	1.93e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—AKT1—atherosclerosis	1.73e-06	1.93e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL6—atherosclerosis	1.71e-06	1.91e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—AKT1—atherosclerosis	1.7e-06	1.9e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	1.7e-06	1.89e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	1.58e-06	1.76e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—AKT1—atherosclerosis	1.5e-06	1.67e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—AKT1—atherosclerosis	1.34e-06	1.49e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—AKT1—atherosclerosis	1.23e-06	1.37e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—AKT1—atherosclerosis	1.22e-06	1.36e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—AKT1—atherosclerosis	1.04e-06	1.16e-05	CbGpPWpGaD
